Completed
Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease
NCT00004387
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
Not specified